Allstate Corp Ionis Pharmaceuticals Inc Transaction History

Allstate Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$47.45 - $62.95 $188,566 - $250,163	-3,974 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$46.85 - $61.05 $186,181 - $242,612	3,974 New	3,974 $234,000
Q4 2019 Feb 14, 2020	SELL	$53.85 - $65.27 $652,123 - $790,419	-12,110 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$59.06 - $72.15 $452,813 - $553,174	7,667 Added 172.56%	12,110 $726,000
Q2 2019 Aug 14, 2019	BUY	$62.09 - $86.14 $275,865 - $382,720	4,443 New	4,443 $286,000

402

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $4.96B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Allstate Corp, based on Form 13F filings with the SEC.

Stay updated on Allstate Corp with notifications on news.